A Study of IBI311 in Subjects With Inactive or Active Thyroid Eye Disease
Clinical trial NCT06525506 · COMPLETED
Trial details
- NCT number
- NCT06525506
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-04
- Primary completion
- 2025-01-09
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.